Obstentrics_Williams

Obstentrics_Williams. myelination progresses after birth. This lack of myelin and incomplete skull ossiication permit fetal brain structure to be seen sonographically throughout gestation. Whereas the superior two thirds of the neural tube give rise to the brain, the inferior third forms the spinal cord. In the embryo, the spinal cord extends along the entire vertebral column length, but after that it lags behind vertebral growth. Ossiication of the entire sacrum is visible sonographically by approximately 21 weeks (Chap. 10, p. 191). By 24 weeks, the spinal cord extends to SIiat birth to L3, and in the adult to LI. Spinal cord myelination begins at midgestation and continues through the irst year of life. Synaptic function is suiciently developed by the eighth week to demonstrate flexion of the neck and trunk (Temiras, 1968). During the third trimester, integration of nervous and muscular function proceeds rapidly.


Obstentrics_Williams

Obstentrics_Williams. The embryology of the heart is complex. At its earliest stages of formation, the fetal heart undergoes molecular programming, and more than a hundred genes and molecular factors are integral to its morphogenesis. To summarize, the straight cardiac tube is formed by the 23rd day during an intricate morphogenetic sequence, during which each segment arises at a unique time. The tube then undergoes looping, and the chambers then fuse and form septa (Manner, 2009). The valves develop, and the aortic arch forms by vasculogenesis. For a complete description, refer to Chapter 9 in Hursts he Heart (Keller, 2013).


Obstentrics_Williams

Obstentrics_Williams. his unique circulation is substantially diferent from that of the adult and functions until birth, when it changes dramatically. For example, because fetal blood does not need to enter the pulmonary vasculature to be oxygenated, most of the right ventricular output bypasses the lungs. In addition, the fetal heart chambers work in parallel, not in series, which efectively supplies the brain and heart with more highly oxygenated blood than the rest of the body.


Obstentrics_Williams

Obstentrics_Williams. Oxygen and nutrient materials required for fetal growth and maturation are delivered from the placenta by the single umbilical vein (Fig. 7-9). The vein then divides into the ductus venosus and the portal sinus. The ductus venosus is the major branch of the umbilical vein and traverses the liver to enter the inferior vena cava directly. Because it does not supply oxygen to the intervening tissues, it carries well-oxygenated blood directly to the heart. In contrast, the portal sinus carries blood to the hepatic veins primarily on the left side of the liver, and oxygen is extracted. The relatively deoxygenated blood from the liver then lows back into the inferior vena cava, which also receives more deoxygenated blood returning from the lower body. Blood flowing to the fetal heart from the inferior vena cava, therefore, consists of an admixture of arterial-like blood that passes directly through the ductus venosus and less well-oxygenated blood that returns from most of the veins below


Obstentrics_Williams

Obstentrics_Williams. inferior vena cava, therefore, consists of an admixture of arterial-like blood that passes directly through the ductus venosus and less well-oxygenated blood that returns from most of the veins below the level of the diaphragm. The oxygen content of blood delivered to the heart from the inferior vena cava is thus lower than that leaving the placenta.


Obstentrics_Williams

Obstentrics_Williams. Foramen ovale Umbilical v. Hypogastricaa. Ductus Aorta _ -- FIGURE 7-9 The intricate nature of the fetal circulation is evident. The degree of blood oxygenation in various vessels differs appreciably from that in the postnatal state. aa = arteries; LA = left atrium; LV = left ventricle; RA = right atrium; RV = right ventricle; v = vein.


Obstentrics_Williams

Obstentrics_Williams. As discussed, the ventricles of the fetal heart work in parallel, not in series. Well-oxygenated blood enters the left ventricle, which supplies the heart and brain, and less oxygenated blood enters the right ventricle, which supplies the rest of the body. These two separate circulations are maintained by the right atrial structure, which efectively directs entering blood to either the left atrium or the right ventricle, depending on its oxygen content. his separation of blood according to its oxygen content is aided by the pattern of blood flow in the inferior vena cava. The well-oxygenated blood tends to course along the medial aspect of the inferior vena cava and the less oxygenated blood flows along the lateral vessel wall. This aids their shunting into opposite sides of the heart. Once this blood enters the right atrium, the configuration of the upper interatrial septum-the crista dividens-preferentially shunts the well-oxygenated blood from the medial side of the inferior vena


Obstentrics_Williams

Obstentrics_Williams. this blood enters the right atrium, the configuration of the upper interatrial septum-the crista dividens-preferentially shunts the well-oxygenated blood from the medial side of the inferior vena cava and the ductus venosus through the foramen ovale into the left heart and then to the heart and brain (Dawes, 1962). After these tissues have extracted needed oxygen, the resulting less oxygenated blood returns to the right atrium through the superior vena cava.


Obstentrics_Williams

Obstentrics_Williams. The less oxygenated blood coursing along the lateral wall of the inferior vena cava enters the right atrium and is deflected through the tricuspid valve to the right ventricle. The superior vena cava courses inferiorly and anteriorly as it enters the right atrium, ensuring that less well-oxygenated blood returning from the brain and upper body also will be shunted directly to the right ventricle. Similarly, the ostium of the coronary sinus lies just superior to the tricuspid valve so that less oxygenated blood from the heart also returns to the right ventricle. As a result of this blood flow pattern, blood in the right ventricle is 15 to 20 percent less saturated than blood in the left ventricle.


Obstentrics_Williams

Obstentrics_Williams. lmost 90 percent of blood exiting the right ventricle is shunted through the ductus arteriosus to the descending aorta. High pulmonary vascular resistance and comparatively lower resistance in the ductus arteriosus and the umbilical-placental vasculature ensure that only about 8 percent of right ventricular output goes to the lungs (Fineman, 2014). Thus, one third of the blood passing through the ductus arteriosus is delivered to the body. The remaining right ventricular output returns to the placenta through the two hypogastric arteries. These two arteries course from the level of the bladder along the abdominal wall to the umbilical ring and into the cord as the umbilical arteries. In the placenta, this blood picks up oxygen and other nutrients and is recirculated through the umbilical vein.


Obstentrics_Williams

Obstentrics_Williams. After birth, the umbilical vessels, ductus arteriosus, foramen ovale, and ductus venosus normally constrict or collapse. With the functional closure of the ductus arteriosus and the expansion of the lungs, blood leaving the right ventricle preferentially enters the pulmonary vasculature to become oxygenated before it returns to the left heart (Hillman, 2012). Virtually instantaneously, the ventricles, which had worked in parallel in fetal life, now efectively work in series. The more distal portions of the hypogastric arteries undergo atrophy and obliteration within 3 to 4 days after birth. hese become the umbilicaliligaments, whereas the intraabdominal remnants of the umbilical vein form the ligamentum teres. The ductus venosus constricts by 10 to 96 hours after birth and is anatomically closed by 2 to 3 weeks. This ultimately forms the ligamentum venosum (Fineman, 2014).


Obstentrics_Williams

Obstentrics_Williams. Although precise measurements of human fetoplacental blood volume are lacking, Usher and associates (1963) reported values in term normal newborns to average 78 mLlkg when immediate cord clamping was conducted. Gruenwald (1967) found the fetal blood volume contained in the placenta after prompt cord clamping to average 45 mLlkg of fetal weight. Thus, fetoplacental blood volume at term is approximately 125 mLlkg of fetal weight. This is important when assessing the magnitude of fetomaternal hemorrhage as discussed in Chapter 15 (p. 307).


Obstentrics_Williams

Obstentrics_Williams. In the early embryo, hemopoiesis is demonstrable first in the yolk sac, followed by the liver, and inally spleen and bone marrow. Both myeloid and erythroid cells are continually pro duced by progenitors that are from hematopoietic stem cells (Golub, 2013; Heinig, 2015). The first erythrocytes released into the fetal circulation are nucleated and macrocytic. The mean cell volume is at least 180 L in the embryo and decreases to 105 to 115 L at term. The erythrocytes of aneuploid fetuses mean cell volumes-130 L on average (Sipes, 1991). As fetal development progresses, more and more of the circulating erythrocytes are smaller and nonnucleated. With fetal growth, both the blood volume in the common fetoplacental circu lation and hemoglobin concentration increase. As shown in Figure 7-10, fetal hemoglobin concentrations rise across preg nancy. The Society for Maternal-Fetal Medicine (2015) rec ommends a cutof hematocrit value of 30 percent to define anemia.


Obstentrics_Williams

Obstentrics_Williams. Figure 7-10, fetal hemoglobin concentrations rise across preg nancy. The Society for Maternal-Fetal Medicine (2015) rec ommends a cutof hematocrit value of 30 percent to define anemia. Because of their large size, fetal erythrocytes have a short life span, which progressively lengthens to approximately 90 days at term (Pearson, 1966). As a consequence, red blood cell production rises. Reticulocytes are initially present at high levels, but decrease to 4 to 5 percent of the total at term. Fetal erythrocytes difer structurally and metabolically from those in the adult (Baron, 2012). They are more deformable, which serves to ofset their higher viscosity. They also contain several enzymes with appreciably diferent activities.


Obstentrics_Williams

Obstentrics_Williams. Erythropoiesis is controlled primarily by fetal erythropoietin because maternal erythropoietin does not cross the placenta. Fetal hormone production is influenced by testosterone, estrogen, prostaglandins, thyroid hormone, and lipoproteins (Stockman, 1992). Serum erythropoietin levels rise with fetal maturity. Although the exact production site is disputed, the fetal liver appears to be an important source until renal production begins. There is a close correlation between the erythropoietin concentration in amnionic fluid and that in umbilical venous blood obtained by cordocentesis. After birth, erythropoietin normally may not be detectable for up to 3 months. In contrast, platelet production reaches stable levels by midpregnancy, although there is some variation across gestation (Fig. The fetal and neonatal platelet count is subject to various agents as discussed in Chapter 15 (p. 307).


Obstentrics_Williams

Obstentrics_Williams. The fetal and neonatal platelet count is subject to various agents as discussed in Chapter 15 (p. 307). This tetrameric protein is composed of two copies of two diferent peptide chains, which determine the type of hemoglobin produced. Normal adult hemoglobin A is made of a and 3 chains. During embryonic and fetal life, various a and 3 chain precursors are produced. This results in the serial production of several diferent embryonic hemoglobins. Genes for 3-type chains are on chromosome 11, and those for a-type chains on chromosome 16. Each of these genes is turned on and then of during fetal life, until a and 3 genes, which direct the production of adult hemoglobin A, are permanentlyiactivated.


Obstentrics_Williams

Obstentrics_Williams. FIGURE 7-11 Platelet counts by gestational age obtained the first day of life. Mean values and 5th and 95th percentiles are shown. (Data from Christensen RD, Henry E, Antonio DV: Thrombocytosis and thrombocytopenia in the NICU: incidence, mechanisms and treatments, J Matern Fetal Neonatal Med 2012 Oct;25 SuppIo4:15-17) • •• • •••• • • • •• •• •• • Moderateanemia • • ,• •• Mildanemia • Severeanemia•• • • 1.16 :JA12 0.84 ) 0.65 0.55 ) :;)I S FIGURE 7-10 Relationship between fetal hemoglobin across gestational age. Blue dots indicate fetuses with hydrops. (Reproduced with permission from Mari G, Deter RL, Carpenter RL, et al: Noninvasive diagnosis by Doppler ultrasonography offetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment ofthe Blood Velocity in Anemic Fetuses (Level II-I), N Engl J Med 2000 Jan 6;342(1 ):9-14.)


Obstentrics_Williams

Obstentrics_Williams. The timing ofproduction ofeach ofthese earlyhemoglobins corresponds to the site of hemoglobin production. Fetal blood is first produced in the yolk sac, where hemoglobins Gower 1, Gower 2, and Portland are made. Erythropoiesis then moves to the liver, where fetal hemoglobin F is produced. When hemopoiesis finally moves to the bone marrow, adult-type hemoglobin A appears in fetal red blood cells and is present in progressively greater amounts as the fetus matures (Pataryas, 1972).


Obstentrics_Williams

Obstentrics_Williams. he final adult version of the . chain is produced exclusively by 6 weeks. Mter this, there are no functional alternative 400,000 /95th :J:LD 300,000 200,000 ::D)5 ) 100,000 24262830323436384042 versions. Ifan a-gene mutation or deletion occurs, no alternate a-type chain can be substituted to form functional hemoglobin. In contrast, at least two versions of the � chain-6 and ,-remain in production throughout fetal life and beyond. In the case ofa �-gene mutation or deletion, these two other versions of the � chain often continue to be produced, resulting in hemoglobin A2 or hemoglobin F, which substitute for the abnormal or missing hemoglobin.


Obstentrics_Williams

Obstentrics_Williams. Genes are turned of by methylation of their control region, which is discussed in Chapter 13 (p. 267). In some situations, methylation does not occur. For example, in newborns ofdiabetic women, hemoglobin F may persist due to hypomethylation of thei, gene (Perrine, 1988). With sickle cell anemia, thei, gene remains unmethylated, and large quantities of fetal hemoglobin continue to be produced. s discussed in Chapter 56 (p. 1081), elevated hemoglobin F levels are associated with fewer sickle-cell disease symptoms, and pharmacological modiication ofthese levels by hemoglobin F-inducing drugs is one approach to treatment.


Obstentrics_Williams

Obstentrics_Williams. As discussed on page 140, there is a functional diference between hemoglobins A and F. At any given oxygen tension and at identical pH, fetal erythrocytes that contain mostly hemoglobin F bind more oxygen than do those that contain nearly all hemoglobin A (Fig. 47-2, p. 920). his is because hemoglobin A binds 2,3-diphosphoglycerate (2,3-DPG) more avidly than does hemoglobin F, thus lowering the ainity of hemoglobin A for oxygen. During pregnancy, maternal 2,3-DPG levels are greater, and because fetal erythrocytes have lower concentrations of 2,3-DPG, the latter has increased oxygen ainity. he amount of hemoglobin F in fetal erythrocytes begins to decrease in the last weeks of pregnancy. At term, approximately three fourths oftotal hemoglobin levels are hemoglobin F. During the irst 6 to 12 months of life, the hemoglobin F proportion continues to decline and eventually reaches the low levels found in adult erythrocytes.


Obstentrics_Williams

Obstentrics_Williams. With the exception of fibrinogen, there are no embryonic forms of the various hemostatic proteins. he fetus starts producing normal, adult-type procoagulant, ibrinolytic, and anticoagulant proteins by 12 weeks. Because they do not cross the placenta, their concentrations at birth are markedly below the levels that develop within a few weeks of life (Corrigan, 1992). In normal neonates, the levels of factors II, VII, IX, X, XI, and of protein S, protein C, antithrombin, and plasminogen all approximate 50 percent of adult levels. In contrast, levels of factors V, VIII, XIII, and ibrinogen are closer to adult values (Saracco, 2009). Without prophylactic treatment, the levels of vitamin K-dependent coagulation factors usually decrease even further during the irst few days after birth. his decline is ampliied in breastfed infants and may lead to newborn hemorrhage (Chap. 33, p. 626).


Obstentrics_Williams

Obstentrics_Williams. Fetal ibrinogen, which appears as early as 5 weeks, has the same amino acid composition as adult ibrinogen, however, it has diferent properties (Klagsbrun, 1988). It forms a less compressible clot, and the ibrin monomer has a lower degree of aggregation (Heimark, 1988). Although plasma ibrinogen levels at birth are less than those in nonpregnant adults, the protein is functionally more active than adult ibrinogen (Ignjatovic, 2011). Levels of functional fetal factor XIII-ibrin stabilizing factor-are signiicantly reduced compared with those in adults (Henriksson, 1974). Nielsen (1969) described low levels of plasminogen and elevated ibrinolytic activity in cord plasma compared with that of maternal plasma. Platelet counts in cord blood are in the normal range for nonpregnant adults (see Fig. 7-11).


Obstentrics_Williams

Obstentrics_Williams. Despite this relative reduction in procoagulants, the fetus appears to be protected from hemorrhage, and fetal bleeding is rare. Even after invasive fetal procedures such as cordocentesis, excessive bleeding is uncommon. Ney and coworkers (1989) have shown that amnionic luid thromboplastins and a factor(s) in Wharton jelly combine to aid coagulation at the umbilical cord puncture site. Various thrombophilias may cause thromboses and pregnancy complications in adults (Chap. 52, p. 1008). If the fetus inherits one of these mutations, thrombosis and infarction can develop in the placenta or fetal organs. his is usually seen with homozygous inheritance. One example is homozygous protein C mutation, which causes purpura fulminans.


Obstentrics_Williams

Obstentrics_Williams. Liver enzymes and other plasma proteins are produced by the fetus, and these levels do not correlate with maternal levels (Weiner, 1992). Concentrations of plasma proteins, which include albumin, lactic dehydrogenase, aspartate aminotransferase, 1-glutamyl transpeptidase, and alanine transferase, all rise. Conversely, prealbumin levels decline with gestational age (Fryer, 1993). At birth, mean total plasma protein and albumin concentrations in fetal blood are similar to maternal levels. This is important because albumin binds unconjugated bilirubin to prevent kernicterus in the newborn (Chap. 33, p. 626).


Obstentrics_Williams

Obstentrics_Williams. Lung maturation and biochemical indices of functional fetal lung maturity are important predictors of early neonatal outcome. Morphological or functional immaturity at birth leads to the development of the respiratoy distress syndrome (Chap. 34, p. 636). A suicient amount of surface-active materialscollectively referred to as suactant-in the amnionic fluid is evidence of fetal lung maturity. As Liggins (1994) emphasized, however, the structural and morphological maturation of fetal lung also is extraordinarily important to proper lung function.


Obstentrics_Williams

Obstentrics_Williams. The limits of viability appear to be determined by the usual process of pulmonary growth. Like the branching of a tree, lung development proceeds along an established timetable that apparently cannot be hastened by antenatal or neonatal therapy. Within this framework, four essential lung development stages are described by Moore (2000). First, the pseudoglandular stage entails growth of the intrasegmental bronchial tree between the 5th and 17th weeks. During this period, the lung looks microscopically like a gland. Second, during the canalicular stage, from 16 to 25 weeks, the bronchial cartilage plates extend peripherally. Each terminal bronchiole gives rise to several respiratory bronchioles, and each of these in turn divides into multiple saccular ducts. Third, the terminal sac stage begins after 25 weeks. During this stage, alveoli give rise to primitive pulmonary alveoli, that is, the terminal sacs. Simultaneously, an extracellular matrix develops from proximal to distal lung


Obstentrics_Williams

Obstentrics_Williams. begins after 25 weeks. During this stage, alveoli give rise to primitive pulmonary alveoli, that is, the terminal sacs. Simultaneously, an extracellular matrix develops from proximal to distal lung segments until term. Finally, the alveolar stage begins during the late fetal period and continues well into childhood. An extensive capillary network is built, the lymph system forms, and type II pneumocytes begin to produce surfactant. At birth, only approximately 15 percent of the adult number of alveoli is present. hus, the lung continues to grow, adding more alveoli for up to 8 years.


Obstentrics_Williams

Obstentrics_Williams. Various insults can upset this process, and their timing determines the sequelae. One example is fetal renal agenesis, in which amnionic luid is absent at the beginning oflung growth, and major defects occur in all four developmental stages. In another instance, the fetus with membrane rupture and subsequent oligohydramnios before 20 weeks usually exhibits nearly normal bronchial branching and cartilage development but has immature alveoli. In contrast, membrane rupture after 24 weeks may have minimal long-term efect on pulmonary structure. In another example, various growth factors are expressed abnormally in the fetus with a diaphragmatic hernia (Candilira, 2015). Finally, vitamin D is thought to be important for several aspects oflung development (Hart, 2015; Lykkedegn, 2015).


Obstentrics_Williams

Obstentrics_Williams. After the irst breath, the terminal sacs must remain expanded despite the pressure imparted by the tissue-to-air interface, and surfactant keeps them from collapsing. Surfactant is formed in type II pneumonocytes that line the alveoli. These cells are characterized by multivesicular bodies that produce the lamellar bodies in which surfactant is assembled. During late fetal life, at a time when the alveolus is characterized by a waterto-tissue interface, the intact lamellar bodies are secreted from the lung and swept into the amnionic fluid during respiratorylike movements that are termed fetal breathing. At birth, with the first breath, an air-to-tissue interface is established in the lung alveolus. Surfactant uncoils from the lamellar bodies and spreads to line the alveolus to prevent alveolar collapse during expiration. hus, the fetal lungs' capacity to produce surfactant establishes lung maturity.


Obstentrics_Williams

Obstentrics_Williams. Surfactant Composition. Gluck (1972) and Hallman (1976) and their coworkers approximated that 90 percent of surfactant's dry weight is lipid, speciically glycerophospholipids. Proteins account for the other 10 percent. Nearly 80 percent of the glycerophospholipids are phosphatidylcholines (lecithins). The principal active component that constitutes half of surfactant is a speciic lecithin, which is dipalmitoylphosphatidylcholine (DPPC or PC). Phosphatidylglycerol (PG) accounts for another 8 to 15 percent. Its precise role is unclear because newborns without PG usually do well. he other major constituent is phosphatidylinositol (PI). The relative contributions of each component are shown in Figure 7-12.


Obstentrics_Williams

Obstentrics_Williams. Surfactant Synthesis. Biosynthesis takes place in the type II pneumocytes. he apoproteins are produced in the endoplasmic reticulum, and the glycerophospholipids are synthesized by cooperative interactions of several cellular organelles. Phospholipid is the primary surface tension-lowering component of surfactant, whereas the apoproteins aid the forming and reforming of a surface ilm. The major apoprotein is surfactant A (SP-A), which is a glycoprotein with a molecular weight of 28,000 to 35,000 Da (Whitsett, 1992). It is synthesized in the type II cells, and its content in amnionic fluid increases with gestational age and fetal lung maturity. SP-A gene expression is demonstrable by 29 weeks (Mendelson, 2005). Specifically, SP-Ai and SP-A2 0: : o . 15 -.a are two separate genes on chromosome 10, but their regulation is distinctive and diferent (McCormick, 1994).


Obstentrics_Williams

Obstentrics_Williams. 15 -.a are two separate genes on chromosome 10, but their regulation is distinctive and diferent (McCormick, 1994). Several smaller apoproteins such as SP-B and SP-C are likely important in optimizing the action of surfactant. For example, deletions.in SP-B gene are incompatible with survival despite production of large amounts of surfactant (Hallman, 2013). Corticosteroids and Fetal Lung Maturation. Since Liggins (1969) observed accelerated lung maturation in lamb fetuses given glucocorticosteroids prior to preterm delivery, many suggested that fetal cortisol stimulates lung maturation and surfactant synthesis. It is unlikely that corticosteroids are the only stimulus for augmented surfactant formation. However, when these are administered at certain critical times, they may improve preterm fetal lung maturation. As fetal lung therapy, antenatal betamethasone and dexamethasone use and neonatal replacement surfactant therapy are discussed in Chapter 34 (p. 637).


Obstentrics_Williams

Obstentrics_Williams. Fetal respiratory muscles develop early, and chest wall movements are detected sonographically as early as 11 weeks (Koos, 2014). From the beginning of the fourth month, the fetus engages in respiratory movement suiciently intense to move amnionic luid in and out of the respiratory tract. Some extrauterine events have efects on fetal breathing, for example, maternal exercise stimulates it (Sussman, 2016). After its embryogenic formation from the yolk sac as the primordial gut, the digestive system forms the intestines and various appendages. The foregut gives rise to the pharynx, lower respiratory system, esophagus, stomach, proximal duodenum, liver, pancreas, and biliary tree. The midgut gives rise to the distal duodenum, jejunum, ileum, cecum, appendix, and the right colon. The hindgut develops into the left colon, rectum, and the superior portion of the anal canal. Numerous malformations develop in these structures from improper rotation, ixation, and partitioning.


Obstentrics_Williams

Obstentrics_Williams. Swallowing begins at 10 to 12 weeks, coincident with the ability of the small intestine to undergo peristalsis and actively transport glucose (Koldovsky, 1965). As a correlate, neo ..A:.A : 0 of immature gut motility (Singendonk, 2014). Much of the water in swallowed luid is absorbed, and unabsorbed matter o). ::) 0-0.. .-o i:S :.=. 0 is propelled to the lower colon. Gitlin (1974) demonstrated that late in pregnancy, approximately 800 mg of soluble pro tein is ingested daily by the fetus. he stimulus for swallow :.o)B : 0 ing is unclear, but the fetal neural analogue of thirst, gastric o : 0 :.=.=t ..A emptying, and change in the amnionic fluid composition are potential factors (Boyle, 1992). The fetal taste buds may play a role because saccharin injected into amnionic fluid increases ..At 40 swallowing, whereas injection of a noxious chemical inhibits it Gestational age (weeks) (Liley, 1972). Fetal swallowing appears to have little efect on amnionic


Obstentrics_Williams

Obstentrics_Williams. Gestational age (weeks) (Liley, 1972). Fetal swallowing appears to have little efect on amnionic FIGURE 7-12 Relationship between the levels of lecithindipalmitoyl phosphatidylcholine (PC), phosphatidylinositol (PI), and fluid volume early in pregnancy because the volume swallowed phosphatidylglycerol (PG) in amnionic fluid. is small compared with the total. However, term fetuses swallow between 200 and 760 mL per day-an amount comparable to that of the term neonate (Pritchard, 1966). hus at term, amnionic fluid volume regulation can be substantially altered by fetal swallowing. For example, as discussed in Chapter 11 (p. 227), if swallowing is inhibited, hydramnios is common.


Obstentrics_Williams

Obstentrics_Williams. Hydrochloric acid and some digestive enzymes are pres ent in the stomach and small intestine in minimal amounts in the early fetus. Intrinsic factor is detectable by 11 weeks, and pepsinogen by 16 weeks. The preterm neonate, depending on its gestational age, may have transient deficiencies of these enzymes (Lebenthal, 1983). Stomach emptying appears to be stimulated primarily by volume. Movement of amnionic luid through the gastroin testinal system may enhance growth and development of the alimentary canal. That said, other regulatory factors likely are involved. For example, anencephalic fetuses, in which swallow ing is limited, often have normal amnionic fluid volume and normal-appearing gastrointestinal tract.


Obstentrics_Williams

Obstentrics_Williams. Fetal bowel contents consist of various products of secretion, such as glycerophospholipids from the lung, desquamated fetal cells, lanugo, scalp hair, and vernix. It also contains undigested debris from swallowed amnionic fluid. The dark greenish-black color forms from bile pigments, especially biliverdin. Meconium can pass from normal bowel peristalsis in the mature fetus or from vagal stimulation. It can also pass when hypoxia stimulates arginine vasopressin (A VP) release from the fetal pituitary gland. A VP stimulates colonic smooth muscle to contract, resulting in intraamnionic defecation (deVane, 1982; Rosenfeld, 1985). Meconium is toxic to the respiratory system, and its inhalation can result in meconium aspiration syndrome (Chap. 33, p. 620).


Obstentrics_Williams

Obstentrics_Williams. The hepatic diverticulum is an outgrowth of the endodermal lining of the foregut. Epithelial liver cords and primordial cells diferentiate into hepatic parenchyma. Serum liver enzyme levels increase with gestational age. Still, the fetal liver has a gestational-age-related diminished capacity for converting free unconjugated bilirubin to conjugated bilirubin (Morioka, 2015). Because of hepatic immaturity, the preterm newborn is at particular risk for hyperbilirubinemia (Chap. 33, p. 626). And because the life span of normal fetal macrocytic erythrocytes is shorter than that of the adult, relatively more unconjugated bilirubin is produced. As just noted, the fetal liver conjugates only a small fraction, and this is excreted into the intestine and ultimately oxidized to biliverdin. Most of the unconjugated bilirubin is excreted into the amnionic luid after 12 weeks and transferred across the placenta (Bashore, 1969).


Obstentrics_Williams

Obstentrics_Williams. Importantly, placental bilirubin transfer is bidirectional. Thus, a woman with severe hemolysis from any cause has excess unconjugated bilirubin that readily passes to the fetus and then into the amnionic fluid. Conversely, conjugated bilirubin is not exchanged to any significant degree between mother and fetus. Most fetal cholesterol derives from hepatic synthesis, which satisies the large demand for low-density lipoprotein (LDL) cholesterol by the fetal adrenal glands. Hepatic glycogen is present in low concentration during the second trimester, but near term, levels rise rapidly and markedly to reach concentrations that are two-to threefold higher than those in the adult liver. After birth, glycogen content falls precipitously.


Obstentrics_Williams

Obstentrics_Williams. from the endoderm of the foregut. Gene regulation of its development was recently reviewed Qennings, 2015). Insu lin-containing granules can be identiied by 9 to 10 weeks, and insulin is detectable in fetal plasma at 12 weeks (Adam, 1969). The pancreas responds to hyperglycemia by secreting insulin (Obenshain, 1970). Glucagon has been identified in the fetal pancreas at 8 weeks. Although hypoglycemia does not cause an increase in fetal glucagon levels, similar stimuli do so by 12 hours after birth (Chez, 1975). At the same time, however, fetal pancreatic a cells do respond to L-dopa infu sions (Epstein, 1977). Therefore, unresponsiveness to hypo glycemia is likely the consequence of failed glucagon release rather than inadequate production. This is consistent with developmental expression of pancreatic genes in the fetus (Mally, 1994).


Obstentrics_Williams

Obstentrics_Williams. Most pancreatic enzymes are present by 16 weeks. T rypsin, chymotrypsin, phospholipase A, and lipase are found in the 14-week fetus, and their concentrations increase with gestational age (Wedin, 1992). Amylase has been identiied in amnionic luid at 14 weeks (Davis, 1986). The exocrine function of the fetal pancreas is limited. Physiologically important secretion occurs only after stimulation by a secretagogue such as acetylcholine, which is released locally after vagal stimulation (Werlin, 1992). Cholecystokinin normally is released only after protein ingestion and thus ordinarily would not be found in the fetus.


Obstentrics_Williams

Obstentrics_Williams. Renal development involves interaction between pluripotential stem cells, undiferentiated mesenchymal cells, and epithelial components (Fanos, 2015). Two primitive urinary systemsthe pronephros and the mesonephros-precede development of the metanephros, which forms the inal kidney (Chap. 3, p. 33). The pronephros involutes by 2 weeks, and the mesonephros produces urine at 5 weeks and degenerates by 11 to 12 weeks. Failure of these two structures either to form or to regress may result in anomalous urinary system development. Between 9 and 12 weeks, the ureteric bud and the nephrogenic blastema interact to produce the metanephros. he kidney and ureter develop from intermediate mesoderm. The bladder and urethra develop from the urogenital sinus. The bladder also develops in part from the allantois.


Obstentrics_Williams

Obstentrics_Williams. By week 14, the loop of Henle is functional and reabsorption occurs (Smith, 1992). New nephrons continue to be formed until 36 weeks. In preterm neonates, their formation continues after birth. Although the fetal kidneys produce urine, their ability to concentrate and modiy the pH is limited even in the mature fetus. Fetal urine is hypotonic with respect to fetal plasma and has low electrolyte concentrations.


Obstentrics_Williams

Obstentrics_Williams. Renal vascular resistance is high, and the filtration fraction is low compared with adult values (Smith, 1992). Fetal renal blood low and thus urine production are controlled or inluenced by the renin-angiotensin system, the sympathetic nervous system, prostaglandins, kallikrein, and atrial natriuretic peptide. The glomerular filtration rate increases with gestational age from less than 0.1 mLimin at 12 weeks to 0.3 mLi min at 20 weeks. In later gestation, the rate remains constant when corrected for fetal weight (Smith, 1992). Hemorrhage or hypoxia generally results in a decrease in renal blood flow, glomerular filtration rate, and urine output. Urine usually is found in the bladder even in small fetuses.


Obstentrics_Williams

Obstentrics_Williams. Urine usually is found in the bladder even in small fetuses. The fetal kidneys start producing urine at 12 weeks. By 18 weeks, they are producing 7 to 14 mLi day, and at term, this increases to 650 mLiday (Wladimirof, 1974). Maternally administered furosemide increases fetal urine formation, whereas uteroplacental insuiciency, fetal growth restriction, and other fetal disorders can lower it. Obstruction of the urethra, bladder, ureters, or renal pelves can damage renal parenchyma and distort fetal anatomy (Muller Brochut, 2014). Kidneys are not essential for survival in utero but inluence control of amnionic luid composition and volume. hus, abnormalities that cause chronic fetal anuria are usually accompanied by oligohydramnios and pulmonary hypoplasia. Pathological correlates and prenatal therapy of urinary tract obstruction are discussed in Chapter 16 (p. 325).


Obstentrics_Williams

Obstentrics_Williams. The fetal endocrine system is functional for some time before the central nervous system reaches maturity (Mulchahey, 1987). he anterior pituitary gland develops from oral ectodermRathke pouch, whereas the posterior pituitary gland derives from neuroectoderm. As with other organ systems, embryonic development involves a complex and highly spatiotemporally regulated network of signaling molecules and transcription factors (Bancalari, 2012; de Moraes, 2012). Anterior and Intermediate Lobes. The adenohypophysis, or anterior pituitary, diferentiates into five cell types that secrete six protein hormones. Of these types, lactotropes produce prolactin (PRL), somatotropes produce growth hormone (GH), corticotropes produce adrenocorticotropic hormone (ACTH), thyrotropes produce thyroid-stimulating hormone (TSH), and gonadotropes produce luteinizing hormone (LH) and folliclestimulating hormone (FSH).


Obstentrics_Williams

Obstentrics_Williams. ACTH is irst detected in the fetal pituitary gland at 7 weeks, and GH and LH have been identified by 13 weeks. By the end of the 17th week, the fetal pituitary gland synthesizes and stores all pituitary hormones. Moreover, the fetal pituitary is responsive to tropic hormones and is capable of secreting these early in gestation (Grumbach, 1974). he fetal pituitary secretes �-endorphin, and cord blood levels of �-endorphin and �-lipotrophin rise with fetal PC02 (Browning, 1983). The intermediate lobe in the fetal pituitary gland is well developed. The cells of this structure begin to disappear before term and are absent from the adult pituitary. he principal secretory products of the intermediate lobe cells are .-melanocytestimulating hormone (.-MSH) and �-endorphin.


Obstentrics_Williams

Obstentrics_Williams. Neurohypophysis. The posterior pituitary gland or neurohypophysis is well developed by 10 to 12 weeks, and oxytocin and arginine vasopressin are demonstrable. Both hormones probably unction in the fetus to conserve water by actions directed largely at the lung and placenta rather than kidney. Vasopressin levels in umbilical cord plasma are increased strikingly compared with maternal levels (Chard, 1971).


Obstentrics_Williams

Obstentrics_Williams. This gland arises from the endoderm of the second pharyngeal pouch. he thyroid migrates to its inal position and the obliterated thyroglossal duct connects to the foramen cecum of the tongue. he pituitary-thyroid system is functional by the end of the first trimester. The thyroid gland is able to synthesize hormones by 10 to 12 weeks, and thyrotropin, thyroxine, and thyroid-binding globulin (TBG) have been detected in fetal serum as early as 11 weeks (Bernal, 2007). he placenta actively concentrates iodide on the fetal side, and by 12 weeks and throughout pregnancy, the fetal thyroid concentrates iodide more avidly than does the maternal thyroid. hus, maternal administration of either radioiodide or appreciable amounts of ordinary iodide is hazardous after this time (Chap. 58, p. 1121). Normal fetal levels of free thyroxine (T4), free triiodothyronine (T3)' and thyroxin-binding globulin increase steadily throughout gestation (Ballabio, 1989). Compared with adult levels, by 36 weeks,


Obstentrics_Williams

Obstentrics_Williams. Normal fetal levels of free thyroxine (T4), free triiodothyronine (T3)' and thyroxin-binding globulin increase steadily throughout gestation (Ballabio, 1989). Compared with adult levels, by 36 weeks, fetal serum concentrations of TSH are higher, total and free T3 concentrations are lower, and T4 is similar. This suggests that the fetal pituitary may not become sensitive to feedback until late pregnancy (horpeBeeston, 1991).


Obstentrics_Williams

Obstentrics_Williams. Fetal thyroid hormone plays a role in the normal development of virtually all fetal tissues, especially the brain (Forhead, 2014; Rovet, 2014). Its inluence is illustrated by congenital hyperthyroidism, which develops when maternal thyroidstimulating antibody crosses the placenta to stimulate the fetal gland to secrete thyroxine (Donnelley, 2015). These fetuses develop large goiters as shown in Figure 58-3 (p. 1121). They also display tachycardia, hepatosplenomegaly, hematological abnormalities, craniosynostosis, and growth restriction. As children, they have perceptual motor diiculties, hyperactivity, and reduced growth (Wenstrom, 1990). Fetal thyroid disease and its treatment are discussed in Chapter 16 (p. 318) . Neonatal efects of fetal thyroid deficiency are discussed in Chapter 58 (p. 1126).


Obstentrics_Williams

Obstentrics_Williams. The placenta prevents substantial passage of maternal thyroid hormones to the fetus by rapidly deiodinating maternal T 4 and T 3 to form reverse T 3' a relatively inactive thyroid hormone (Vulsma, 1989). Several antithyroid antibodies cross the placenta when present in high concentrations (Pelag, 2002). Those include the long-acting thyroid stimulators (LATS), LATSprotector (LATS-P), and thyroid-stimulating immunoglobulin (TSI). It was previously believed that normal fetal growth and development, which occurred despite fetal hypothyroidism, provided evidence that T 4 was not essential for fetal growth. It is now known, however, that growth proceeds normally because small quantities of maternal T4 prevent antenatal cretinism in fetuses with thyroid agenesis (Forhead, 2014; Vulsma, 1989).


Obstentrics_Williams

Obstentrics_Williams. The fetus with congenital hypothyroidism typically does not develop stigmata of cretinism until after birth (Abduljabbar, 2012). Because administration of thyroid hormone will prevent this, by state law, all newborns are tested for high serum levels ofTSH (Chap. 32, p. 614). Immediately after birth, thyroid function and metabolism undergo major change. Cooling to room temperature evokes sudden and marked increase in TSH secretion. his in turn causes a progressive increase in serum T 4 levels that are maximal 24 to 36 hours after birth. here are nearly simultaneous eleva tions of serum T levels.


Obstentrics_Williams

Obstentrics_Williams. These glands develop from two separate tissues. The medulla derives from neural crest ectoderm, whereas the fetal and adult cortex arise from intermediate mesoderm. The gland grows rapidly through cell proliferation and angiogenesis, cellular migration, hypertrophy, and apoptosis (Ishimoto, 2011). Fetal glands are much larger in relation to total body size than in adults. he bulk is made up of the inner or fetal zone of the adrenal cortex and involutes rapidly after birth. his zone is scant to absent in rare instances in which the fetal pituitary gland is congenitally absent. he function of the fetal adrenal glands is discussed in detail in Chapter 5 (p. 104).


Obstentrics_Williams

Obstentrics_Williams. Infections in utero have provided an opportunity to examine mechanisms of the fetal immune response. Evidence of immunological competence has been reported as early as 13 weeks (Kohler, 1973; Stabile, 1988). In cord blood at or near term, the average level for most components is approximately half that of the adult values (Adinolfi, 1977). B cells diferentiate from pluripotent hemopoietic stem cells that migrate to the liver (Melchers, 2015; Muzzio, 2013). Despite this, in the absence of a direct antigenic stimulus such as infection, fetal plasma immunoglobulins consist almost totally of transferred maternal immunoglobulin G (IgG). hus, antibodies in the newborn are most often relective of maternal immunological experiences (American College of Obstetricians and Gynecologists, 2017). he interaction between maternal and fetal T cells is described in detail in Chapter 5 (p. 95).


Obstentrics_Williams

Obstentrics_Williams. Maternal IgG transport to the fetus begins at approximately 16 weeks and increases thereafter. he bulk of IgG is acquired during the last 4 weeks of pregnancy (Gitlin, 1971). Accordingly, preterm neonates are poorly endowed with protective maternal antibodies. Newborns begin to slowly produce IgG, and adult values are not attained until age 3 years. In certain situations, the transfer of IgG antibodies from mother to fetus can be harmful rather than protective to the fetus. The classic example is hemolytic disease of the fetus and newborn resulting from Rh-antigen alloimmunization (Chap. 15, p. 301). In the adult, production of immunoglobulin M (IgM) in response to an antigenic stimulus is superseded in a week or so predominantly by IgG production. In contrast, very little


Obstentrics_Williams

Obstentrics_Williams. In the adult, production of immunoglobulin M (IgM) in response to an antigenic stimulus is superseded in a week or so predominantly by IgG production. In contrast, very little IgM is produced by normal fetuses. With infection, the IgM response is dominant in the fetus and remains so for weeks to months in the newborn. And, because IgM is not trans ported from the mother, any IgM in the fetus or newborn is that which it produced. hus, specific IgM levels in umbilical cord blood may be useful in fetal infection diagnosis. Accord ing to the American College of Obstetricians and Gynecologists (2017), elevated levels of IgM are usually found in newborns with congenital infection such as rubella, cytomegalovirus infection, or toxoplasmosis. In infants, adult levels of IgM are normally attained by age 9 months. mucosal protection against enteric infections. This may explain the small amount of fetal secretory IgA found in amnionic luid (Quan, 1999).


Obstentrics_Williams

Obstentrics_Williams. mucosal protection against enteric infections. This may explain the small amount of fetal secretory IgA found in amnionic luid (Quan, 1999). he immune system develops early, and B lymphocytes appear in fetal liver by 9 weeks and in blood and spleen by 12 weeks. T lymphocytes begin to leave the thymus at approximately 14 weeks. Despite this, the newborn responds poorly to immunization, and especially poorly to bacterial capsular polysaccharides. his immature response may stem from a deicient response of newborn B cells to polyclonal activators or from a lack of T cells that proliferate in response to specific stimuli (Hayward, 1983). In the newborn, monocytes are able to process and present antigen when tested with maternal antigen-speciic T cells. DNA methylation patterns are developmentally regulated during monocyte-macrophage diferentiation and contribute to the antiinlammatory phenotype in macro phages (Kim, 2012).


Obstentrics_Williams

Obstentrics_Williams. The origin of most muscles and bones is mesodermal. he skeleton arises from condensed mesenchyme-embryonic connective tissue-which eventually forms hyaline cartilage models of the bones. By the end of the embryonic period, ossification centers have developed, and bones harden by endochondral ossification. The limb buds appear by the fourth week. Most skeletal muscle derives from myogenic precursor cells in the somites. Because of the small amount of yolk in the human ovum, growth of the embryofetus is dependent on maternal nutrients during the irst 2 months. During the first few days after implantation, blastocyst nutrition comes from the interstitial fluid of the endometrium and the surrounding maternal tissue.


Obstentrics_Williams

Obstentrics_Williams. Maternal adaptations to store and transfer nutrients to the fetus are discussed in Chapter 4 and summarized here. Three major maternal storage depots are the liver, muscle, and adipose tissue. These maternal depots and the storage hormone insulin are intimately involved in the metabolism of the nutrients absorbed from the gut. Maternal insulin secretion is sustained by increased serum levels of glucose and amino acids. he net efect is maternal storage of glucose as glycogen primarily in liver and muscle, retention of some amino acids as protein, and storage of the excess as fat. Storage of maternal fat peaks in the second trimester and then declines as fetal energy demands rise in the third trimester (Pipe, 1979). Interestingly, the placenta appears to act as a nutrient sensor, altering transport based on the maternal supply and environmental stimuli (Fowden, 2006; Jansson, 2006b).


Obstentrics_Williams

Obstentrics_Williams. During times of fasting, glucose is released from glycogen, but maternal glycogen stores cannot provide an adequate amount of glucose to meet requirements for maternal energy and fetal growth. Augmentation is provided by cleavage of triacylglycerols, stored in adipose tissue, which result in free fatty acids and activation of lipolysis.


Obstentrics_Williams

Obstentrics_Williams. Although dependent on the mother for nutrition, the fetus also actively participates in providing its own nutrition. At midpregnancy, fetal glucose concentration is independent of maternallevels and may exceed them (Bozzetti, 1988). Glucose is the major nutrient for fetal growth and energy. Logically, mechanisms exist during pregnancy to minimize maternal glucose use so that the limited maternal supply is available to the fetus. Human placental lactogen (hPL), a hormone normally abundant in the mother bur not the fetus, has an insulin antagonist efect. It blocks the peripheral uptake and use of glucose, while promoting mobilization and use of free fatty acids by maternal tissues (Chap. 5, p. 100). his hormone is also diabetogenic as discussed in Chapter 57 (p. 1107).


Obstentrics_Williams

Obstentrics_Williams. he transfer of D-glucose across cell membranes is accomplished by a carrier-mediated, stereospecific, nonconcentrating process of facilitated difusion. There are 14 glucose transport proteins (GLUTs) encoded by the SLC2A gene family and characterized by tissue-speciic distribution (Leonce, 2006). GLUT-1 and GLUT -3 primarily facilitate glucose uptake by the placenta and are located in the plasma membrane of the syncytiotrophoblast microvilli (Acosta, 2015). DNA methylation regulates expression of placental GLUT genes, with epigenetic modiication across gestation (Novakovic, 2013). It increases as pregnancy advances and is induced by almost all growth factors (Frolova, 2011). GLUT-3 expression is up regulated with fetal growth restriction a anzen, 2013). Lactate is a product of glucose metabolism and transported across the placenta also by facilitated difusion. By way of cotransport with hydrogen ions, lactate is probably transported as lactic acid.


Obstentrics_Williams

Obstentrics_Williams. Lactate is a product of glucose metabolism and transported across the placenta also by facilitated difusion. By way of cotransport with hydrogen ions, lactate is probably transported as lactic acid. The precise biomolecular events in the pathophysiology of fetal macrosomia are not deined. Nonetheless, fetal hyperinsulinemia is clearly one driving force (Luo, 2012). As discussed in Chapter 44 (p. 845), insulin-like growth factor, fibroblast growth factor, and corticotropin-releasing hormone (CRH) and are important regulators of placental development and function (Gao, 2012; Giudice, 1995). Maternal obesity begets fetal macrosomia (Chap. 44, p. 857). In addition, it is hypothesized that maternal obesity afects fetal cardiomyocyte growth that may result in fetal cardiomyopathy or even congenital heart disease (Roberts, 2015).


Obstentrics_Williams

Obstentrics_Williams. This polypeptide hormone was originally identified as a product of adipocytes and a regulator of energy homeostasis by curbing appetite. It also contributes to angiogenesis, hemopoiesis, osteogenesis, pulmonary maturation, and neuroendocrine, immune, and reproductive functions (Brifa, 2015; Maymo, 2009). Leptin is produced by the mother, fetus, and placenta. It is expressed in syncytiotrophoblast and fetal vascular endothelial cells. Of placental production, 5 percent enters the fetal circulation, whereas 95 percent is transferred to the mother (Hauguel-de vlouzon, 2006). Leptin concentrations peak in amnionic fluid at midpregnancy (Scott-Finley, 2015).


Obstentrics_Williams

Obstentrics_Williams. Fetalileptin levels begin rising at approximately 34 weeks and are correlated with fetal weight. This hormone is involved in the development and maturation of the heart, brain, kidneys, and pancreas, and its levels are decreased with fetal growth restriction (Brifa, 2015). Abnormal levels have been associated with fetal growth disorders, gestational diabetes, and preeclampsia (Fasshauer, 2014). Postpartum, leptin levels decline in both the newborn and mother. Perinatal leptin is associated with the development of metabolic syndromes later in life (Brifa, 2015; Granado, 2012).


Obstentrics_Williams

Obstentrics_Williams. The newborn has a large proportion of fat, which averages 15 percent of body weight (Kimura, 1991). Thus, late in pregnancy, a substantial part of the substrate transferred to the human fetus is stored as fat. Although maternal obesity raises placental fatty acid uptake and fetal fat deposition, it does not appear to afect fetal organ growth (Dube, 2012). Neutral fat in the form of triglycerides does not cross the placenta, but glycerol does. Despite this, evidence supports that abnormal maternal concentrations of triglycerides-both low and high levels-are associated with major congenital anomalies (Nederlof, 2015).


Obstentrics_Williams

Obstentrics_Williams. There is preferential placental-fetal transfer of long-chain polyunsaturated fatty acids (Gil-Sanchez, 2012). Lipoprotein lipase is present on the maternal but not on the fetal side of the placenta. his arrangement favors hydrolysis of triacylglycerols in the maternal intervillous space yet preserves these neutral lipids in fetal blood. Fatty acids transferred to the fetus can be converted to triglycerides in the fetal liver.


Obstentrics_Williams

Obstentrics_Williams. The placental uptake and use ofLDL is an alternative mechanism for fetal assimilation of essential fatty acids and amino acids (Chap. 5, p. 103). LDL binds to specific receptors in the coated-pit regions of the syncytiotrophoblast microvilli. The large LDL particle, measuring about 250,000 Da, is taken up by a process of receptor-mediated endocytosis. The apoprotein and cholesterol esters of LD L are hydrolyzed by lysosomal enzymes in the syncytium to yield: (1) cholesterol for progesterone synthesis; (2) free amino acids, including essential amino acids; and (3) essential fatty acids, primarily linoleic acid.


Obstentrics_Williams

Obstentrics_Williams. he placenta concentrates many amino acids in the syncytiotrophoblast, which are then transferred to the fetal side by difusion. Based on data from cordocentesis blood samples, the amino acid concentration in umbilical cord plasma is greater than in maternal venous or arterial plasma (Morriss, 1994) . Transport system activity is influenced by gestational age and environmental factors. hese include heat stress, hypoxia, under-and overnutrition, and hormones such as glucocorticoids, growth hormone, and leptin (Brifa, 2015; Fowden, 2006). Trophoblastic mammalian target of rapamycin complex 1 (mTORC1) regulates placental amino acid transporters and modulates transfer across the placenta Qansson, 2012). In vivo studies suggest an upregulation of transport for certain amino acids and a greater delivery rate of these to the fetuses of women with gestational diabetes associated with fetal overgrowth Oansson, 2006a).


Obstentrics_Williams

Obstentrics_Williams. Placental transfer of larger proteins is limited, but there are exceptions. IgG crosses the placenta in large amounts via endocytosis and trophoblast Fc receptors. IgG transfer depends on maternal levels of total IgG, gestational age, placental integrity, IgG subclass, and antigenic potential (Palmeira, 2012). Conversely, the larger immunoglobulins-IgA and IgM-of maternal origin are efectively excluded from the fetus.


Obstentrics_Williams

Obstentrics_Williams. Calcium and phosphorus are actively transported from mother to fetus. Calcium is transferred for fetal skeletal mineralization (Olausson, 2012). A calcium-binding protein is produced in placenta. Parathyroid hormone-related protein (PTH-rP), as the name implies, acts as a surrogate PTH in many systems (Chap. 5, p. 102). PTH is not found in fetal plasma, but PTHrP is present, suggesting that PTH-rP is the fetal parathormone. The expression of PTH-rP in cytotrophoblasts is modulated by the extracellular concentration of Ca2+ (Hellman, 1992). It seems possible, therefore, that PTH-rP synthesized in decidua, placenta, and other fetal tissues is important in fetal Cai+ transfer and homeostasis.


Obstentrics_Williams

Obstentrics_Williams. Iodide transport is clearly attributable to a carrier-mediated, energy-requiring active process. And indeed, the placenta concentrates iodide. he concentrations of zinc in the fetal plasma also are greater than those in maternal plasma. Conversely, copper levels in fetal plasma are less than those in maternal plasma. his fact is of particular interest because important copperrequiring enzymes are necessary for fetal development. Placental Sequestration of Heavy Metals he heavy metal-binding protein metallothionein-1 is expressed in human syncytiotrophoblast. his protein binds and sequesters a host of heavy metals, including zinc, copper, lead, and cadmium. Despite this, fetal exposure is variable (Caserta, 2013). For example, lead enters the fetal environment at a level 90 percent of maternal concentrations. In contrast, placental transfer of cadmium is limited (Kopp, 2012). he most common source of environmental cadmium is cigarette smoke.


Obstentrics_Williams

Obstentrics_Williams. Metallothionein also binds and sequesters copper (Cu2+) in placental tissue. This accounts for the low levels of Cu2+ in cord blood (Iyengar, 2001). It is possible that cadmium provokes metallothionein synthesis in the amnion. his may cause Cu2+ sequestration, a pseudo-copper deficiency, and in turn, diminished tensile strength of the amnion. he concentration of vitamin A (retinol) is greater in fetal than in maternal plasma and is bound to retinol-binding protein and to prealbumin. Retinol-binding protein is transferred from the maternal compartment across the syncytiotrophoblast. The transport of vitamin C-ascorbic acid-from mother to fetus is accomplished by an energy-dependent, carrier-mediated process. Levels of principal vitamin D metabolites, including 1,25-dihydroxycholecalciferol, are greater in maternal plasma than in fetal plasma. The 1 3-hydroxylation of 25-hydroxyvitamin D3 is known to take place in placenta and in decidua.


Obstentrics_Williams

Obstentrics_Williams. The placenta is the organ of transfer between mother and fetus. Within this maternal-fetal interface, oxygen and nutrients transfer from the mother to the fetus, whereas CO2 and meta bolic wastes are directed from fetus to mother. Fetal blood, which is contained in the fetal capillaries of the chorionic villi, has no direct contact with maternal blood, which remains in the intervillous space. Instead, bidirectional transfer depends on processes that allow or aid the transport through the syncy tiotrophoblast that lines chorionic villi.


Obstentrics_Williams

Obstentrics_Williams. Over the past few years, it has become apparent that breaks in the chorionic villi permit escape of fetal cells and other bloodborne material into the maternal circulation. This leakage is the mechanism by which some D-negative women become sensitized by the erythrocytes of their D-positive fetus (Chap. 15, p. 301). In fact, after 10 weeks, 10 to 15 percent of cell-free DNA (cDNA) in maternal plasma is placental in origin, that is, trophoblastic DNA (Norton, 2012). he escape of fetal cells can also lead to fetal microchimerism from entrance of allogeneic fetal cells, including trophoblast, into maternal blood and other organs (Rijnik, 2015). Volumes are estimated to range from 1 to 6 cells/ mL at midpregnancy. Some fetal cells become "immortal" in that they persist in the maternal circulation and organs following pregnancy. As discussed in Chapter 59 (p. 1139), the clinical corollary is that some maternal autoimmune diseases may be provoked by such microchimerism.


Obstentrics_Williams

Obstentrics_Williams. • The Intervillous Space vIaternal blood within the intervillous space is the primary source of maternal-fetal transfer. Blood from the maternal spiral arteries directly bathes the trophoblast layer that surrounds the villi. Substances transferred from mother to fetus irst enter the intervillous space and are then transported to the syncytiotrophoblast. As such, the chorionic villi and intervillous space function together as the fetal lung, gastrointestinal tract, and kidney. Circulation within the intervillous space is described in Chapter 5 (p. 94). Intervillous and uteroplacental blood flow increases throughout the irst trimester of normal pregnancies (Merce, 2009). At term, the residual volume of the intervillous space approximates 140 mL. Moreover, utero placental blood flow near term is estimated to be 700 to 900 mLl min, and most of this blood apparently goes to the intervillous space (Pates, 2010).


Obstentrics_Williams

Obstentrics_Williams. Active labor contractions reduce blood low into the intervillous space to a degree that depends on contraction intensity. Blood pressure within the intervillous space is significantly less than uterine arterial pressure, but somewhat greater than venous pressure. he latter, in turn, varies depending on several factors, including maternal position (Nelson, 2015). When supine, for example, pressure in the lower part of the inferior vena cava is elevated, and consequently, pressure in the uterine and ovarian veins, and in turn in the intervillous space, is increased.


Obstentrics_Williams

Obstentrics_Williams. Substances that pass from maternal to fetal blood must irst traverse the syncytiotrophoblast, the attenuated cytotrophoblast layer, the villous stroma, and inally, the fetal capillary wall. Although this histological barrier separates maternal and fetal circulations, it is not a simple physical barrier. First, throughout pregnancy, syncytiotrophoblast actively or passively permits, facilitates, and adjusts the amount and rate of substance transfer to the fetus. The maternal-facing syncytiotrophoblast surface is characterized by a complex microvillous structure. he fetal-facing basal cell membrane is the site of transfer to the intravillous space. Finally, the villous capillaries are an additional site for transport from the intravillous space into fetal blood, or vice versa. In determining the efectiveness of the human placenta as an organ of transfer, several variables are important and shown in Table


Obstentrics_Williams

Obstentrics_Williams. Zhao and coworkers (2014) have provided a review of the pharmacology of these interactions. Mechanisms of Transfer Most substances with a molecular mass <500 Da pass readily through placental tissue by simple difusion. These include TABLE 7-1. Variables of Maternal-Fetal Substance binding of the substance Maternal blood flow rate through the intervillous space Trophoblast surface area size available for exchange Physical trophoblast properties to permit simple difusion Trophoblast biochemical machinery for active transport Substance metabolism by the placenta during transfer Fetal intervillous capillary surface area size for exchange Fetal blood concentration of the substance


Obstentrics_Williams

Obstentrics_Williams. Specific binding or carrier proteins in the fetal or maternal ci rcu lation oxygen, CO2, water, most electrolytes, and anesthetic gases (Carter, 2009). Some low-molecular-weight compounds undergo transfer facilitated by syncytiotrophoblast. These are usually those that have low concentrations in maternal plasma but are essential for normal fetal development. Insulin, steroid hormones, and thyroid hormones cross the placenta, but very slowly. he hormones synthesized in situ in the syncytiotrophoblast enter both the maternal and fetal circulations, but not equally (Chap. 5, p. 98). Examples are hCG and hPL concentrations, which are much lower in fetal plasma than in maternal plasma. High-molecularweight substances usually do not traverse the placenta, but there are important exceptions. One is immunoglobulin G-molecular weight 160,000 Da-which is transferred by way of a speciic trophoblast receptor-mediated mechanism (Stach, 2014). Transfer of Oxygen and Carbon Dioxide


Obstentrics_Williams

Obstentrics_Williams. Transfer of Oxygen and Carbon Dioxide Placental oxygen transfer is blood flow limited. Using estimated uteroplacental blood low, Longo (1991) calculated oxygen delivery to be approximately 8 mL 02/min/kg of fetal weight. Normal values for oxygen and CO2 are presented in Figure 7-13. Because of the continuous passage of oxygen from maternal blood in the intervillous space to the fetus, its oxygen saturation resembles that in maternal capillaries. The average oxygen saturation of intervillous blood is estimated to be 65 to 75 percent, with a partial pressure (P02) of 30 to 35 mm Hg. ;: 50 .N 30 . 2010 n = 58 1 mm Hg approx. = 0.•133 kPa


Obstentrics_Williams

Obstentrics_Williams. ;: 50 .N 30 . 2010 n = 58 1 mm Hg approx. = 0.•133 kPa FIGURE 7-13 Umbilical venous cordocentesis samples obtained in fetuses being evaluated for possible intrauterine infections or hemolysis, but who were found to be healthy. A. Oxygen pressure (PoJ B. Carbon dioxide pressure (Pco2). Shaded areas represent 5th to 95th percentiles. (Modified from Ramsey, MM: Normal Values in Pregnancy. Ramsay MM, James OK, Steer PJ, et al (eds). London, Elsevier, 1996, p 106.) The oxygen saturation of umbilical vein blood is similar but has a somewhat lower oxygen partial pressure. Fetal hemoglobin has a higher oxygen ainity than adult hemoglobin. This is illustrated by the oxyhemoglobin disassociation curve, which is described in Chapter 47 (p. 920).


Obstentrics_Williams

Obstentrics_Williams. he placenta is highly permeable to CO2, which traverses the chorionic villus by diusion more rapidly than oxygen. Near term, the partial pressure of carbon dioxide (PC02) in the umbilical arteries averages 50 mm Hg, which is approximately 5 mm Hg higher than in the maternal intervillous blood. Fetal blood has less ainity for CO2 than does maternal blood, thereby favoring CO2 transfer from fetus to mother. Also, mild maternal hyperventilation results in a fall in Pc02ilevels, favoring a transfer of CO2 from the fetal compartment to maternal blood.


Obstentrics_Williams

Obstentrics_Williams. Although simple difusion is an important method of placental transfer, the trophoblast and chorionic villus unit demonstrate enormous selectivity in transfer. his results in diferent metabolite concentrations on the two sides of the villus. Importantly, the levels of many substances that are not synthesized by the fetus are several times higher in fetal than in maternal blood. Ascorbic acid is one example. his relatively low-molecularweight substance might be expected to traverse the placenta by simple difusion. he concentration of ascorbic acid, however, is two to four times higher in fetal plasma than in maternal plasma (Morriss, 1994). Another example is the unidirectional transfer of iron. Typically, maternal plasma iron concentration is much lower than that in her fetus. Even with severe maternal iron-deficiency anemia, the fetal hemoglobin mass is normal. Abduljabbar MS, ii M: Congenital hypothyroidism. ] Pediatr Endocrinol Metab 25(102)13, 2012


Obstentrics_Williams

Obstentrics_Williams. Abduljabbar MS, ii M: Congenital hypothyroidism. ] Pediatr Endocrinol Metab 25(102)13, 2012 Acosta 0, Ramirez I, Lager S, et al: Increased glucose and placental GLUT-1 in large infants of obese nondiabetic mothers. Am ] Obstet Gynecol 212(2):227.e1,s2015 Adam PA, Teramo K, Raiha N, et al: Human fetal insulin metabolism early in gestation: response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-13l. Diabetes 18:409,s1969 Adinoli M: Human complement: onset and site of synthesis during fetal life. Am] Dis Child 131:1015,s1977 American College of Obstetricians and Gynecologists: CytOmegalovirus, parvovirus B 19, varicella zoster, and tOxoplasmosis in pregnancy. Practice Bulletin No. 151,] une 2015, Reairmed 2017


Obstentrics_Williams

Obstentrics_Williams. American College of Obstetricians and Gynecologists: CytOmegalovirus, parvovirus B 19, varicella zoster, and tOxoplasmosis in pregnancy. Practice Bulletin No. 151,] une 2015, Reairmed 2017 American College of Obstetricians and Gynecologists: ACOG reinvents the pregnancy wheel. 2016. Available at: http://www.acog.org/About-ACOG/ N ews-Room/N ews-Releasesl20 161 ACOG-Reinven ts-the-PregnancyWheel. Accessed April 8, 2016 Anderson RH, Brown NA, Mohun T]: Insights regarding the normal and abnormal formation of the atrial and ventricular septal structures. Clin Anat 29(3):290,s2016 Ballabio M, Nicolini U, Jowett T, et al: Maturation of thyroid function in normal human foetuses. Clin Endocrinol 31 :565, 1989 Bancalari E, Gregory LC, McCabe M], et al: Pituitary gland development: an update. Endocr Dev 23:1,s2012 Baron MH, Isern ], Fraser ST: The embryonic origins of erythropoiesis in mammals. Blood 119(21):4828,s2012


Obstentrics_Williams

Obstentrics_Williams. Baron MH, Isern ], Fraser ST: The embryonic origins of erythropoiesis in mammals. Blood 119(21):4828,s2012 Bashore A, Smith F, Schenker S: Placental transfer and disposition of bilirubin in the pregnant monkey. Am] Obstet Gynecols103:950, 1969 Bernal ]: hyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3:249, 2007 Boyle ]T: Motility of the upper gastrointestinal tract in the fetus and neonate. In Polin A, Fox WW (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1992, p 1028 Bozzetti P, Ferrari MM, Marconi M, et al: The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism 37:358, 1988 Brifa ]F, McAinch AG, Romano T, et al: Leptin in pregnancy and development: a contributOr to adulthood disease? Am ] Physiol Endocrinol Metab 308:E335,s2015


Obstentrics_Williams

Obstentrics_Williams. Brifa ]F, McAinch AG, Romano T, et al: Leptin in pregnancy and development: a contributOr to adulthood disease? Am ] Physiol Endocrinol Metab 308:E335,s2015 Browning A]F, Butt WR, Lynch SS, et al: Maternal plasma concentrations of 3-lipotropin, 3-endorphin and �-lipotropin throughout pregnancy. B]OG 90: 1147, 1983 Candilira V, Bouche C, Schleef K, et al: Lung growth factOrs in the amniotic luid of normal pregnancies and with congenital diaphragmatic hernia. ] Matern Fetal Neonatal Med 3:1, 2015 Carter M: Evolution of factors afecting placental oxygen transfer. Placenta 30(Suppl A):19, 2009 Caserta 0, Graziano A, Lo Monte G, et al: Heavy metals and placental fetalmaternal barrier: a mini-review on the major concerns. Eur Rev Med Phar macol Sci 17(16):198,s2013 Chard T, Hudson CN, Edwards CR, et al: Release of oxytocin and vasopressin by the human foetus during labour. Narure 234:352, 1971


Obstentrics_Williams

Obstentrics_Williams. Chard T, Hudson CN, Edwards CR, et al: Release of oxytocin and vasopressin by the human foetus during labour. Narure 234:352, 1971 Chez A, Mintz DH, Reynolds WA, et al: Maternal-fetal plasma glucose relationships in late monkey pregnancy. Am ] Obstet Gynecol 121 :938, 1975 Christensen RD, Henry E, Antonio DV: hrombocytOsis and thrombocytOpenia in the NICU: incidence, mechanisms and treatments. ] Matern Fetal Neonat Med 25(54):15, 2012 Corrigans]] ]r: Normal hemostasis in the fetus and newborn: Coagulation. In Polin A, Fox WW (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1992, p 1368 Davis MM, Hodes ME, Munsick A, et al: Pancreatic amylase expression in human pancreatic development. Hybridoma 5:137, 1986


Obstentrics_Williams

Obstentrics_Williams. Davis MM, Hodes ME, Munsick A, et al: Pancreatic amylase expression in human pancreatic development. Hybridoma 5:137, 1986 Dawes GS: The umbilical circulation. Am] Obstet Gynecol 84: 1634, 1962 de Moraes DC, Vaisman M, Conceidio FL, et al: Pituitary development: a complex, temporal regulated process dependent on speciic transcriptional factors.s] EndocrinoIs215(2):239, 2012 deVane GW, Naden RP, Porter ]C, et al: Mechanism of arginine vasopressin release in the sheep fetus. Pediatr Res 16:504, 1982 DiPietro ]A: Neurobehavioral assessment before birth. MRDD Res Rev 11 :4, 2005 Donnelley MA, Wood C, Casey B, et al: Early severe fetal Graves disease in a mother after thyroid ablation and thyroidectomy. Obstet Gynecol 125(5):1059,s2015 Dube E, Gravel A, Martin C, et al: Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta. BioI Reprod 87(1):14, 2012


Obstentrics_Williams

Obstentrics_Williams. Dube E, Gravel A, Martin C, et al: Modulation of fatty acid transport and metabolism by maternal obesity in the human full-term placenta. BioI Reprod 87(1):14, 2012 Dubois ], Dehaene-Lambertz G, Kulilova S, et al: he early development of brain white matter: a review of imaging studies in fetuses, newborns and infants. Neuroscience 12:276,s2014 Duryea EL, Hawkins ]S, McIntire DO, et al: A revised birth weight reference for the United States. Obstet GynecoIs124(1):16, 2014 Duryea EL, McIntire DO, Leveno K]: The rate of preterm birth in the United States is afected by the method of gestational age assignment. Am ] Obstet GynecoIs213:331.e1,2015 Epstein M, Chez A, Oakes GK, et al: Fetal pancreatic glucagon responses in glucose-intOlerant nonhuman primate pregnancy. Ams] Obstet Gynecol 127:268, 1977 Fanos V, Loddo C, Puddu M, et al: From ureteric bud to the irst glomeruli: genes, mediators, kidney alterations. Int U rol Nephrol 47(1): 109, 20s15


Obstentrics_Williams

Obstentrics_Williams. Fanos V, Loddo C, Puddu M, et al: From ureteric bud to the irst glomeruli: genes, mediators, kidney alterations. Int U rol Nephrol 47(1): 109, 20s15 Fasshauer M, Bliiher M, Stumvoll M: Adipolines in gestational diabetes. Lancet Diabetes EndocrinoIs2(6):488, 2014 Fineman ]R, Clyman R: Fetal cardiovascular physiology. In Resnik R, Creasy RK, lams ]0, et al (eds): Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice, 7th ed. Philadelphia, Saunders, 2014, p 147 Forhead A], Fowden L: Thyroid hormones in fetal growth and prepartum maturation.s] EndocrinoIs221(3):R87, 2014 Fowden AL, Ward ]W, Wooding FP, et al: Programming placental nutrient transport capacity. ] Physiol 572(1):5, 2006 Frolova AI, Moley KH: Quantitative analysis of glucose transporter mNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology 152(5):2123, 2011


Obstentrics_Williams

Obstentrics_Williams. Frolova AI, Moley KH: Quantitative analysis of glucose transporter mNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine receptivity. Endocrinology 152(5):2123, 2011 Fryer A, Jones P, Strange R, et al: Plasma protein levels in normal human fetuses: 13-41 weeks' gestation. B]OG 100:850, 1993 Gao L, Lv C, Xu C, et al: Diferential regulation of glucose transporters mediated by CRH receptor type 1 and type 2 in human placental trophoblasts. Endocrinology 153:1464,s2012 Gil-Sanchez A, Koletzko B, Larque E: Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care 15(3):265,s2012 Gitlin D: Development and metabolism of the immune globulins. In Kaga BM, Stiehm ER (eds): Immunologic Incompetence. Chicago, Year Book, 1971 Gitlin D: Protein transport across the placenta and protein turnover between amnionic fluid, maternal and fetal circulation. In Moghissi KS, Hafez ESE (eds): he Placenta. Springfield, Thomas, 19


Obstentrics_Williams

Obstentrics_Williams. Gitlin D: Protein transport across the placenta and protein turnover between amnionic fluid, maternal and fetal circulation. In Moghissi KS, Hafez ESE (eds): he Placenta. Springfield, Thomas, 19 Giudice LC, de-Zegher F, Gargosky SE, et al: Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548, 1995 Gluck L, Kulovich MV, Eidelman AI, et a1: Biochemical development of surface activity in mammalian lung. 4. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of [he respiratory distress syndrome. Pediatr Res 6:81, 1972 Goetzl L, Darbinian N, Goetzl EJ: Probing early human neural development through fetal exosomes in maternal blood. Abstract No. Ill. Am J Obstet 7,s2016 Golub R, Cumano A: Embryonic hematopoiesis. Blood Cells Mol Dis 51(4):226,s2013


Obstentrics_Williams

Obstentrics_Williams. Golub R, Cumano A: Embryonic hematopoiesis. Blood Cells Mol Dis 51(4):226,s2013 Granado M, Fuente-Martin E, Garcia-Caceres C, et al: Leptin in early life: a key factor for the development of the adult metabolic proile. Obes Facts 5(1):138,s2012 Gtuenwald P: Growth of the human foetus. In McLaren A (ed): Advances in Reproductive Physiology. New York, Academic Press, 1967 Grumbach MM, Kaplan SL: Fetal pituitary hormones and the maturation of central nervous system regulation of anterior pituitary function. In Gluck L (ed): Modern Perinatal Medicine. Chicago, Year Book, 1974 Hadlock FP, Harrist RB, Martinez-Poyer J: In urero analysis of fetal growth: a sonographic weight standard. Radiology 181(1):129,s1991 Hallman M: The surfactant system protects both fetus and newborn. Neonatology 103(4):320,s2013 Hallman M, Kulovich MV, Kirkpatrick E, et al: Phosphatidylinositol and phosphatidylglycerol in amniotic luid: indices of lung maturity. Am J Obstet Gynecol 125:613, 1976


Obstentrics_Williams

Obstentrics_Williams. Hallman M, Kulovich MV, Kirkpatrick E, et al: Phosphatidylinositol and phosphatidylglycerol in amniotic luid: indices of lung maturity. Am J Obstet Gynecol 125:613, 1976 Hart PH, Lucas RM, Walsh JP, et al: Vitamin D in fetal development: indings from a birth cohort study. Pediatrics 135(1):eI67, 2015 Hauguel-de Mouzon S, Lepercq J, Catalano P: The known and unknown of leptin in pregnancy. Am J Obstet GynecoIs193(6):1537, 2006 Hayward AR: The human fetus and newborn: development of the immune response. Birth Defects 19:289, 1983 Heimark R, Schwartz S: Cellular organization of blood vessels in development and disease. In Ryan U (ed): Endothelial Cells, Vol II. Boca Raton, CRC Press, 1988, p 103 Heinig K, Sage F, Robin C, et al: Development and traicking function ofhaematopoietic stem cells and myeloid cells during fetal ontogeny. Cardiovasc Res 10 (3):352,s2015


Obstentrics_Williams

Obstentrics_Williams. Heinig K, Sage F, Robin C, et al: Development and traicking function ofhaematopoietic stem cells and myeloid cells during fetal ontogeny. Cardiovasc Res 10 (3):352,s2015 Hellman P, Ridefelt P, Juhlin C, et al: Parathyroid-like regulation of parathyroid hormone related protein release and cytoplasmic calcium in cytotrophoblast cells of human placenta. Arch Biochem Biophys 293: 1 4, 1992 Henriksson P, Hedner V, Nilsson 1M, et al: Fibrin-stabilization factor XIII in the fetus and the newborn infant. Pediatr Res 8:789, 1974 Hillman NH, Kallapur SG, Jobe AH: Physiology of transition from intrauterine to extrauterine life. Clin PerinatoI39(4):769, 2012 Ignjatovic V, I1han A, Monagle P: Evidence for age-related diferences in human ibrinogen. Blood Coagul Fibrinolysis 22(2): 11 0, 2011 Iruretagoyena JL, Davis W, Bird C, et a1: Diferential changes in gene expression in human brain during late irst trimester and early second trimester of pregnancy. Prenat Diagn 34(5) :431, 2014


Obstentrics_Williams

Obstentrics_Williams. Iruretagoyena JL, Davis W, Bird C, et a1: Diferential changes in gene expression in human brain during late irst trimester and early second trimester of pregnancy. Prenat Diagn 34(5) :431, 2014 Ishimoto H, Jafe RB: Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr Rev 32(3):317, 2011 Iyengar GV, Rapp A: Human placenta as a "dual" biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 3: Toxic trace elements in placenta and placenta as a biomarker for these elements. Sci Total Environ 280:221, 2001 Jansson T, Aye IL, Goberdhan DC: The emerging role of mTORCl signaling in placental nutrient-sensing. Placenta 33(Suppl 2):e23, 2012 Jansson T, Cetin I, Powell TL, et al: Placental transport and metabolism in fetal overgrowth-a workshop report. Placenta 27:109, 2006a


Obstentrics_Williams

Obstentrics_Williams. Jansson T, Cetin I, Powell TL, et al: Placental transport and metabolism in fetal overgrowth-a workshop report. Placenta 27:109, 2006a Jansson T, Powell TL: Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? A review. Placenta 27:S91, 2006b Janzen C, Lei MY, Cho J, et a1: Placental glucose transporter 3(GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction. Placenta 34(11): 2, 2013 Jennings E, Berry A, Strutt JP, et al: Human pancreas development 142(18):3126,s2015 Kadic AS, Predojevic M: Fetal neurophysiology according to gestational age. Semin Fetal Neonatal Med 17(5):256, 2012 Keller BB, Hoying JB, Markwald RR: Molecular development of the heart. In Fuster V, Walsh A, Harrington A, et al (eds): Hurst's he Heart, 13th ed. New York, McGraw-Hill, 2013, p 1


Obstentrics_Williams

Obstentrics_Williams. Keller BB, Hoying JB, Markwald RR: Molecular development of the heart. In Fuster V, Walsh A, Harrington A, et al (eds): Hurst's he Heart, 13th ed. New York, McGraw-Hill, 2013, p 1 Kim ST, Romero R, Tarca L: Methylome of fetal and maternal monocytes and macro phages at the feto-maternal interface. Am J Reprod Immunol 68(1):8,s2012 Kimura E: Lipid metabolism in the fetal-placental unit. In Cowett RM (ed): Principles of Perinatal-Neonatal Metabolism. New York, Springer, 1991, p 291 K1agsbrun M: Angiogenesis factors. In Ryan U (ed): Endothelial Cells, Vol II. Boca Raton, CRC Press, 1988, p 37 Kohler PF: Maturation of the human complement system. J Clin Invest 52:671, 1973 Koldovsky 0, Heringova A, Jirsova U, et a1: Transport of glucose against a concentration gradient in everted sacs of jejunum and ileum of human fetuses. Gastroenterology 48:185, 1965 Koos BJ, Rajaee A: Fetal breathing movements and changes at birth. Adv Exp Med BioI 814:89, 2014


Obstentrics_Williams

Obstentrics_Williams. Koos BJ, Rajaee A: Fetal breathing movements and changes at birth. Adv Exp Med BioI 814:89, 2014 Kopp RS, Kumbarrski M, Harth V, et al: Partition of metals in the maternal/fetal unit and lead-associated decreases of fetal iron and manganese: an observational biomonitoring approach. Arch Toxicol 1,2012 Lebenthal E, Lee PC: Interactions of determinants of the ontogeny of the gastrointestinal tract: a uniied concept. Pediatr Res 1: 19, 1983 Leonce J, Brockton N, Robinson S, et a1: Glucose production in the human placenta. Placenta :S103, 2006 Liggins GC: Fetal lung maturation. Aust N Z J Obstet Gynaecol 34:247, 1994 Liggins GC: Premature delivery of fetal lambs infused with glucocorticoids. J EndocrinoIs45:515,s1%9 Liley AW: Disorders of amniotic fluid. In Assali NS (ed): Pathophysiology of Gestation. New York, Academic Press, 1972 Longo LD: Respiration in the fetal-placental unit. In Cowett RM (ed): Principles of Perinatal-Neonatal Metabolism. New York, Springer, 1991, P 304


Obstentrics_Williams

Obstentrics_Williams. Longo LD: Respiration in the fetal-placental unit. In Cowett RM (ed): Principles of Perinatal-Neonatal Metabolism. New York, Springer, 1991, P 304 Luo ZC, Nuyt AM, Delvin E, et al: Maternal and fetal IGF-I and IGF-II levels, fetal growth, and gestational diabetes. J Clin Endocrinol Metab 97(5): 1720, 2012 Lykkedegn S, Sorensen GL, Beck-Nielsen SS, et al: he impact of vitamin D on fetal and neonatal lung maturation. A systematic review. Am J Physiol Lung Cell Mol Physiol 308(7):L587, 2015 Mally MI, Otonkoski T, Lopez AD, et al: Developmental gene expression in the human fetal pancreas. Pediatr Res 36:537, 1994 Manganaro L, Perrone A, Savelli S, et al: Evaluation of normal brain development by prenatal MR imaging. Radiol Med 112:444, 2007 Manner J: he anatomy of cardiac looping: a step towards the understanding of the morphogenesis of several forms of congenital cardiac malformations. Clin nat 22(1):21,s2009


Obstentrics_Williams

Obstentrics_Williams. Manner J: he anatomy of cardiac looping: a step towards the understanding of the morphogenesis of several forms of congenital cardiac malformations. Clin nat 22(1):21,s2009 Mari G, Deter L, Carpenter L, et al: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell a1loimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses (Level II-I). N Engl J Med 342:9, 2000 Maymo JL, Perez Perez A, Sanchez-Margalet V, et al: Up-regulation of placental leptin by human chorionic gonadotropin. Endocrinology 150(1):304, 2009 McCormick SM, Mendelson CR: Human SP-Al and SP-A2 genes are differentially regulated during development and by cAMP and glucocorticoids. Am J Physiol 266:367, 1994 Melchers F: Checkpoints that control B cell development. J Clin Invest 125(6):2203,s2015 Mendelson CR, Condon JC: New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol BioI 93: 113, 2005


Obstentrics_Williams

Obstentrics_Williams. Mendelson CR, Condon JC: New insights into the molecular endocrinology of parturition. J Steroid Biochem Mol BioI 93: 113, 2005 Meng H, Zhang Z, Geng H, et a1: Development of the subcortical brain structures in the second trimester: assessment with 7.0-T MRI. Neuroradiology 54(10):1153,s2012 Merce LT, Barco MJ, Alcazar JL, et al: Intervillous and utero placental circulation in normal early pregnancy and early pregnancy loss assessed by 3-dimensional power Doppler angiography. Am J Obstet Gynecol 200(3):315.el,s2009 Mohun TJ, Weninger WJ: Imaging heart development using high resolution episcopic microscopy. Curr Opin Genet Dev 21(5):573,s2011 Moore L: he Developing Human: Clinically Oriented Embryology, 4th ed. Philadelphia, Saunders, 1988 Moore L, Persaud N, Shiota K: Color Atlas of Clinical Embryology, 2nd ed. Philadelphia, Saunders, 2000, p 150


Obstentrics_Williams

Obstentrics_Williams. Philadelphia, Saunders, 1988 Moore L, Persaud N, Shiota K: Color Atlas of Clinical Embryology, 2nd ed. Philadelphia, Saunders, 2000, p 150 Morioka I, Iwatani S, Koda T, et al: Disorders of bilirubin binding to albumin and bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med 20(1):31,s2015 Morriss FH ]r, Boyd RD, Manhendren 0: Placental transport. In Knobil E, Neills] (eds): The Physiology of Reproduction, Vol II. New York, Raven, 1994, p 813 Mulchahey JJ, DiBlasio AM, Martin MC, et al: Hormone production and peptide regulation of the human fetal pituitary gland. Endocr Rev 8:406, 1987 M.iller Brochut AC, homann 0, Kluwe W, et al: Fetal megacystis: experience of a single tertiary center in Switzerland over 20 years. Fetal Diagn Ther 36(3):215,s2014 Muzzio 0, Zenclussen AC, Jensen F: The role ofB cells in pregnancy: the good and the bad. Am] Reprod Immunol 69(4):408, 2013


Obstentrics_Williams

Obstentrics_Williams. Muzzio 0, Zenclussen AC, Jensen F: The role ofB cells in pregnancy: the good and the bad. Am] Reprod Immunol 69(4):408, 2013 Nederlof M, de Walle HE, van Poppel MN, et a1: Deviant early pregnancy matenal triglyceride levels and increased risk of congenital anomalies: a prospective community-based cohon study. B]OG 122:1176,s2015 Nelson DB, Stewart RD, Matulevicius SA, et al: The efects of matenal position and habitus on maternal cardiovascular parameters as measured by cardiac magnetic resonance. Ams] PerinatoIs32(14):1318, 2015 Ney]A, Fee Sc, Dooley SL, et al: Factors inluencing hemostasis after umbilical vein puncture in vitro. Am] Obstet Gynecol 160:424, 1989 Nielsen NC: Coagulation and ibrinolysin in normal women immediately postpartum and in newborn infants. Acta Obstet Gynecol Scand 48:371, 1969 Norton ME, ]acobsson B, Swamy GK, et al: Cell-free DNA analysis for nonin vasive examination of trisomy. N Engl] Med 2(17):1589,2015


Obstentrics_Williams

Obstentrics_Williams. Novakovic B, Gordon L, Robinson WP, et a1: Glucose as a fetal nutrient: dynamic regulation of several glucose transporter genes by DNA methylation in the human placenta across gestation.] Nutr Biochem 24(1):282, 2013 Obenshain SS, Adam PAl, King KC, et al: Human fetal insulin response to sustained maternal hyperglycemia. N Engls] Med 283:566, 1970 Olausson H, Goldberg GR, Laskey A, et al: Calcium economy in human pregnancy and lactation. Nutr Res Rev 25(1):40,2012 Palmeira P, Quinello C, Silveira-Lessa AL, et al: IgG placental transfer in health and pathological pregnancies. C1in Dev Immunol 2012:985646, 2012 Pataryas HA, Stamatoyannopoulos G: Hemoglobins in human fetuses: evidel1Ce for adult hemoglobin production after the 11 th gestational week. Blood 39:688, 1972 Pates ]A, Hatab MR, McIntire DO, et al: Determining uterine blood low in pregnancy with magnetic resonance imaging. Magn Reson Imaging 28(4):507,s2010 Pearson HA: Recent advances in hematology. ] Pediatr 69:466, 1966


Obstentrics_Williams

Obstentrics_Williams. Pearson HA: Recent advances in hematology. ] Pediatr 69:466, 1966 Pelag 0, Cada S, Peleg A, et al: he relationship berween matenal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99: 1040, 2002 Perrine SP, Greene MF, Cohen A, et al: A physiological delay in human fetal hemoglobin switching is associated with speciic globin DNA hypo methylation. FEBS Lett 228: 139, 1988 Pipe NG], Smith T, Halliday 0, et al: Changes in fat, fat-free mass and body water in human normal pregnancy. B]OG 86:929, 1979 Pritchard ]A: Fetal swallowing and amniotic fluid volume. Obstet Gynecol 28:606, 1966 Quan CP, Forestier F, Bouvet ]P: Immunoglobulins of the human amniotic luid. Am] Reprod Immunol 42:219, 1999 Ramsay MM, James OK, Steer P], et al (eds): Normal Values in Pregnancy. London, Elsevier, 1996, p 106


Obstentrics_Williams

Obstentrics_Williams. Ramsay MM, James OK, Steer P], et al (eds): Normal Values in Pregnancy. London, Elsevier, 1996, p 106 Reddy UM, Abuhamad AZ, Levine 0, et al: Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging workshop. Obstet GynecoIs123(5):1070, 2014 Rijnink EC, Penning ME, Wolterbeek R, et al: Tissue microchimerism is increased during pregnancy: a human autopsy study. Mol Hum Reprod Aug 24,s2015 Roberts VH], Frias AE, Grove KL: Impact of maternal obesity on fetal programming of cardiovascular disease. Physiology 30:224, 2015


Obstentrics_Williams

Obstentrics_Williams. Roberts VH], Frias AE, Grove KL: Impact of maternal obesity on fetal programming of cardiovascular disease. Physiology 30:224, 2015 Rosenfeld CR, Poner JC: Arginine vasopressin in the developing fetus. In Albrecht ED, Pepe GJ (eds): Research in Perinatal Medicine, Vol 4. Perinatal Endocrinology. Ithaca, Perinatology Press, 1985, p 91 Rovet JF: The role of thyroid hormones for brain development and cognitive function. Endocr Dev 26:26, 2014 Rysavy MA, Li L, Bell EF, et al: Berween-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med 372(19):1801,s2015 Saracco P, Parodi E, Fabris C, et al: Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors. Thromb Res 123(6):805,s2009 Scott-Finley M, Woo JG, Habli M, et a1: Standardization of amniotic luid leptin levels and utility in matenal overweight and fetal undergrowth.J Perinatol ,2015


Obstentrics_Williams

Obstentrics_Williams. Scott-Finley M, Woo JG, Habli M, et a1: Standardization of amniotic luid leptin levels and utility in matenal overweight and fetal undergrowth.J Perinatol ,2015 Singendonk MM, Rommel N, Omari TI, et al: Upper gastrointestinal motility: prenatal development and problems in infancy. Nat Rev Gastroenterol Hepatol 11(9):545,s2014 Sipes SL, Weiner CP, Wenstrom KD, et al: The association between fetal karyotype and mean corpuscular volume. Am] Obstet Gynecol 165:1371, 1991 Smith FG, Nakamura KT, Segar JL, et al: In Polin A, Fox W (eds): Fetal and Neonatal Physiology, Vol 2, Chap 114. Philadelphia, Saunders, 1992, p 1187 Society for Matenal-Fetal Medicine, Mari G, Norton ME, et al: Society for Matenal-Fetal Medicine (SMFM) Clinical Guidelines #8: the fetus at risk for anemia-diagnosis and management. Am] Obstet Gynecol 212(6):697, 2015


Obstentrics_Williams

Obstentrics_Williams. Stabile I, Nicolaides KH, Bach A, et al: Complement factors in fetal and maternal blood and amniotic luid during the second trimester of normal pregnancy. BJOG 95:281, 1988 Stach Sc, Brizot Mde L, Liao AW, et al: Transplacental total IgG transfer in rwin pregnancies. Am J Reprod Immunol 72(6):555, 2014 Stockman JA III, deAlarcon PA: Hematopoiesis and granulopoiesis. In Polin A, Fox WW (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1992, p 1327 Sussman 0, Lye S], Wells GO: Impact of matenal physical activity on fetal breathing and body movement-a review. Early Hum Dev 94:53, 2016 Temiras PS, Vernadakis A, Sherwood NM: Development and plasticiry of the nervous system. In AssaJi NS (ed): Biology of Gestation, Vol VII. he Fetus and Neonate .. New York, Academic Press, 1968 Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324:532,s1991


Obstentrics_Williams

Obstentrics_Williams. Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al: Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 324:532,s1991 Usher R, Shephard M, Lind ]: he blood volume of the newbon infant and placental transfusion. Acta Paediatr 52:497, 1963 Volpe JJ: Neurology of the Newborn, 5th ed. Saunders, Philadelphia, 2008, p 85 Vulsma T, Gons MH, De Vijlder JJ: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organi6cation defect or thyroid agenesis. N Engl] Med 321:13, 1989 Weiner CP, Sipes SL, Wenstrom K: The efect of fetal age upon normal fetal laboratory values and venous pressure. Obstet Gynecol 79:713, 1992 Wenstrom KO, Weiner CP, Williamson A, et al: Prenatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 76:513, 1990 Werlin SL: Exocrine pancreas. In Polin A, Fox WW (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1992, p 1047


Obstentrics_Williams

Obstentrics_Williams. Werth B, Tsiaras A: From Conception to Birth: A Life Unfolds. New York, Doubleday, 2002 Whitsett JA: Composition of pulmonary surfactant lipids and proteins. In Polin A, Fox W (eds): Fetal and Neonatal Physiology. Philadelphia, Saunders, 1992, p 941 Wladimirof ]W, Campbell S: Fetal urine-production rates in normal and complicated pregnancy. Lancet 1:151, 1974 Zhao Y, Hebert MF, Venkataramanan R: Basic obstetric pharmacology. Semin 5,s2014 COUNSELING SESSION . . . . . . . . . . . . . . . . . . . . . . . . .. 147 MEDICAL HISTORY. . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 147 GENETIC DISEASES ............................. 149 REPRODUCTIVE HISTORY ........................ 151 PARENTAL AGE ................................ 151 SOCIAL HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152 SCREENING TESTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 153


Obstentrics_Williams

Obstentrics_Williams. SOCIAL HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152 SCREENING TESTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. 153 Pregnancy may be associated with certain diseases that existed bore the inception of pregnancy. As a rule, all diseases which subject the organism to a considerable strain are much more serious when occurring in a pregnant woman.


Obstentrics_Williams

Obstentrics_Williams. -J. Whitridge Williams (1903) he Centers for Disease Control and Prevention (CDC) (2015) defines preconceptional care as "a set of interventions that aim to identiy and modiy biomedical, behavioral, and social risks to a woman's health or pregnancy outcome through prevention and management." To achieve this goal, the CDC has developed an action plan for preconceptional health care in the United States Qohnson, 2006). The American College of Obstetricians and Gynecologists (2017 e) and the Society for Maternal-Fetali1vIedicine (2014) also reairm the importance of preconceptional care, and the following objectives have been established for advancing it: 1. Improve knowledge, attitudes, and behaviors of men and women related to preconceptional health 2. Assure that all childbearing-aged women receive preconceptional care services-including evidence-based risk screening, health promotion, and interventions-that will enable them to enter pregnancy in optimal health 3.


Obstentrics_Williams

Obstentrics_Williams. Reduce risks indicated by a previous adverse pregnancy outcome through interconceptional interventions to prevent or minimize recurrent adverse outcomes 4. Reduce the disparities in adverse pregnancy outcomes


Obstentrics_Williams

Obstentrics_Williams. Reduce the disparities in adverse pregnancy outcomes To illustrate potentilly modifiable conditions, data that describe the health status of women who delivered liveborn neonates in the United States in 2004 are reviewed. Table 8-1 demonstrates the high prevalence of many conditions that may be amenable to intervention during the preconceptional and interpregnancy periods. To be successul, however, strategies that mitigate these potential pregnancy risks must be provided before conception. By the time most women realize they are pregnantusually 1 to 2 weeks ater the first missed period-the embryo has already begun to form. hus, many preventive steps-for example, folic acid to avoid neural-tube defects-will be inefective if initiated at this time. Importantly, up to half of all pregnancies in the United States in 2008 were unplanned according to the Guttmacher Institute (2015), and oten these are at greatest risk.